166 related articles for article (PubMed ID: 26766733)
1. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
Kearns B; Whyte S; Seaman HE; Snowball J; Halloran SP; Butler P; Patnick J; Nickerson C; Chilcott J
Br J Cancer; 2016 Feb; 114(3):327-33. PubMed ID: 26766733
[TBL] [Abstract][Full Text] [Related]
2. Predictors of repeat participation in the NHS bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
[TBL] [Abstract][Full Text] [Related]
3. Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.
Geraghty J; Butler P; Seaman H; Snowball J; Sarkar S; Blanks R; Halloran S; Bodger K; Rees CJ
Br J Cancer; 2014 Nov; 111(11):2156-62. PubMed ID: 25225905
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
[TBL] [Abstract][Full Text] [Related]
6. High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.
Brown JP; Wooldrage K; Wright S; Nickerson C; Cross AJ; Atkin WS
J Med Screen; 2018 Jun; 25(2):70-75. PubMed ID: 28467146
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
[TBL] [Abstract][Full Text] [Related]
8. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
9. Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme.
Kearns B; Whyte S; Chilcott J; Patnick J
Br J Cancer; 2014 Oct; 111(9):1734-41. PubMed ID: 25180767
[TBL] [Abstract][Full Text] [Related]
10. Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.
Fraser CG; Digby J; McDonald PJ; Strachan JA; Carey FA; Steele RJ
J Med Screen; 2012 Mar; 19(1):8-13. PubMed ID: 22156144
[TBL] [Abstract][Full Text] [Related]
11. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
12. Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening programme in England.
Benton SC; Piggott C; Blyuss O; Li SJ; Mathews C; Carroll M; Duffy S
J Med Screen; 2021 Dec; 28(4):426-432. PubMed ID: 33983066
[TBL] [Abstract][Full Text] [Related]
13. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
14. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
[TBL] [Abstract][Full Text] [Related]
15. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
16. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
17. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.
Correia A; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
Prev Med; 2015 Jul; 76():115-22. PubMed ID: 25895843
[TBL] [Abstract][Full Text] [Related]
18. Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy.
Young C; Wood HM; Fuentes Balaguer A; Bottomley D; Gallop N; Wilkinson L; Benton SC; Brealey M; John C; Burtonwood C; Thompson KN; Yan Y; Barrett JH; Morris EJA; Huttenhower C; Quirke P
Clin Cancer Res; 2021 Apr; 27(8):2246-2254. PubMed ID: 33658300
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany.
Brenner H; Hoffmeister M; Birkner B; Stock C
Am J Gastroenterol; 2014 Mar; 109(3):427-35. PubMed ID: 24343548
[TBL] [Abstract][Full Text] [Related]
20. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L
Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
